NASDAQ:VRTX

Vertex Pharmaceuticals Stock News

etoro logo Buy VRTX
*Your capital is at risk
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
These players each are leaders in their specialty areas and have generated billions of dollars in revenue. This list includes a biotech stock, a pharma player, and a medical device company.
Geneos Wealth Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 93.8% in the third quarter, according to the company in its most recent 13F filing wi
Vertex Pharmaceuticals Incorporated (VRTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Hardman Johnston Global Advisors LLC trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 26.9% during the third quarter, according to its most recent Form 13F filin
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company's schedul

The Best Stocks to Invest $50,000 in Right Now

05:41am, Sunday, 11'th Jan 2026
Alphabet is playing to win in the AI market. Micron is arguably the biggest AI bargain around.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX - Get Free Report) EVP Ourania Tatsis sold 4,500 shares of the firm's stock in a transaction on Wednesday, January 7th. The stock was sold at an avera
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the twenty-seven analysts that are covering the company, MarketBeat
HB Wealth Management LLC reduced its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 18.0% during the third quarter, according to its most recent disclosure with the Securi
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $463.86, indicating a -1.24% shift from the previous trading day.
Duncker Streett and Co. Inc. lessened its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 69.5% during the third quarter, according to its most recent filing with the Securiti
Vertex Pharmaceuticals (VRTX) reached $469.68 at the closing of the latest trading day, reflecting a -2.99% change compared to its last close.
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Cerity Partners LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 1.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE